Biotest AG operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Biotest AG with three other
pharmaceutical manufacturers in Europe:
FAES Farma SA
sales of 324.31 million Euro [US$359.55 million]
of which 82%
was Speciality Pharmaceuticals),
(375.41 million Euro [US$416.19 million]
of which 79%
was EVT Execute), and
based in France
(367.94 million Euro [US$407.92 million]
of which 55%
During the year ended December of 2018, sales at
Biotest AG were 400.30 million Euro (US$443.79 million).
increase of 5.9%
versus 2017, when the company's sales were 378.10 million Euro.
Despite this increase, sales are still
below the level achieved in 2016, when Biotest AG
reported sales of 553.10 million Euro.
Sales of Therapy saw an increase
11.1% in 2018, from
313.70 million Euro to 348.50 million Euro.
Not all segments of Biotest AG experienced an increase in sales in 2018:
sales of Plasma and Services fell 22.2% to 45.30 million Euro.